Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1983 1
1986 1
1992 1
1995 1
1996 3
1997 3
2000 1
2001 1
2005 2
2007 5
2008 2
2010 2
2011 2
2012 3
2013 5
2014 4
2015 1
2017 1
2018 2
2019 4
2020 2
2021 5
2022 6
2023 6
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
Emerging Insights into the Impact of Air Pollution on Immune-Mediated Asthma Pathogenesis.
Tuazon JA, Kilburg-Basnyat B, Oldfield LM, Wiscovitch-Russo R, Dunigan-Russell K, Fedulov AV, Oestreich KJ, Gowdy KM. Tuazon JA, et al. Among authors: fedulov av. Curr Allergy Asthma Rep. 2022 Jul;22(7):77-92. doi: 10.1007/s11882-022-01034-1. Epub 2022 Apr 8. Curr Allergy Asthma Rep. 2022. PMID: 35394608 Free PMC article. Review.
Fibroin-Gelatin Composite Stimulates the Regeneration of a Splinted Full-Thickness Skin Wound in Mice.
Arkhipova AY, Kulikov DA, Moisenovich AM, Andryukhina VV, Chursinova YV, Filyushkin YN, Fedulov AV, Bobrov MA, Mosalskaya DV, Glazkova PA, Kulikov AV, Nalivkin AE, Molochkov AV, Semenov DY. Arkhipova AY, et al. Among authors: fedulov av. Bull Exp Biol Med. 2019 Nov;168(1):95-98. doi: 10.1007/s10517-019-04656-0. Epub 2019 Nov 22. Bull Exp Biol Med. 2019. PMID: 31758379
[Efficacy and safety of sampeginterferon β-1a in the treatment of relapsing remitting multiple sclerosis: results of 52 weeks of therapy in a randomized, double-blind clinical trial].
Boyko AN, Boyko OV, Bakhtiyarova KZ, Gusev EI, Dudin VA, Zaslavsky LG, Malkova NA, Parshina YV, Poverennova IY, Siverceva SA, Totolyan NA, Shchur SG, Fedulov AS, Khabirov FA, Bolsun DD, Zinkina-Orikhan AV, Linkova YN, Chernovskaya TV. Boyko AN, et al. Among authors: fedulov as. Zh Nevrol Psikhiatr Im S S Korsakova. 2022;122(1):62-71. doi: 10.17116/jnevro202212201162. Zh Nevrol Psikhiatr Im S S Korsakova. 2022. PMID: 35175704 Clinical Trial. Russian.
57 results